We're asking the big market questions this week. Can you get a profit out of BHP this year? Will you ever make money on Pilbara Minerals and its lithium? And we ask St George Bank's former Chief Economist all about future rate cuts. Are they really now out of reach?
Dr Ross Walker points out some issues with recent studies that have suggested multivitamins do nothing.
Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.
On this week's investing show, Peter Switzer is joined by Julia Lee from Burman Invest, Rudi Filapek-VanDyck from FNArena, Jun Bei Liu from Tribeca Investment Partners and Paul Rickard.
Dr Ross Walker talks about new evidence of the coronavirus, its fatality rates and possible mutations.
Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.
On this week's show, Peter Switzer speaks to Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, AMP Capital's Shane Oliver, Switzer's Paul Rickard and nabtrade's Gemma Dale.
Dr Ross Walker looks at the differences between the Oxford and Pfizer vaccine trials and shares the promising results from both.
Peter Switzer is joined by Marie Brownell (National Manager, Estate Planning) & Jodi Kennedy (General Manager, Charitable Trusts and Philanthropy) from Equity Trustees (ASX:EQT).
Tune in to hear Peter Switzer and Paul Rickard discuss the latest money news and how it affects you.
Julia Lee, Michael Gable, Jun Bei Liu, Paul Rickard and Peter Schiff speak to Peter Switzer.
Peter Switzer speaks to the CEO of Life360 (ASX:360), Christopher Hulls.
Dr Ross Walker looks at the recent findings from the Pfizer vaccine trial.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox